Armed with first-ever FDA nod, Rigel preps May launch for autoimmune drug Tavalisse
admin 18th April 2018 Uncategorised 0After one false alarm, Rigel Pharmaceuticals has officially won FDA approval for its lead product, Tavalisse. The agency greenlighted the therapy to treat a rare disease in which the immune system attacks the body’s own blood-clotting cells.
More: Armed with first-ever FDA nod, Rigel preps May launch for autoimmune drug Tavalisse
Source: fierce